s6y
Company name or ticker
Search
Pivotal bioVenture Partners Fund I U.G.P. Ltd
4
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
Filed
Tuesday, July 28, 2020
Period
Jul 28, 2020
Accession number
0001012975-20-000664
Documents
PRIMARY DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header